{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:51:19Z","timestamp":1791089479064,"version":"4.1.0"},"reference-count":56,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.3892\/ijmm.2013.1611","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T13:01:02Z","timestamp":1388149262000},"page":"711-721","source":"Crossref","is-referenced-by-count":16,"title":["Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis"],"prefix":"10.3892","volume":"33","author":[{"given":"FULIANG","family":"BAI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUI","family":"TIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZESHAN","family":"NIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINGYAO","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUIPING","family":"REN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YINHANG","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIAN","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SIMING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DESHAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,12,27]]},"reference":[{"key":"key20180107231412_b1-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","article-title":"IL-17 as a future therapeutic target for rheumatoid arthritis","volume":"5","author":"van den Berg","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"key20180107231412_b2-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"key20180107231412_b3-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b4-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bcp.2008.11.011","article-title":"Interleukin 17 sustains rather than induces inflammation","volume":"77","author":"Maione","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"key20180107231412_b5-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.trim.2009.03.006","article-title":"A pathogenic role of IL- 17 at the early stage of corneal allograft rejection","volume":"21","author":"Chen","year":"2009","journal-title":"Transpl Immunol"},{"key":"key20180107231412_b6-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2011-200867","article-title":"IL-17 and tumour necrosis factor \u03b1 combination induces a HIF-1\u03b1-dependent invasive phenotype in synoviocytes","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key20180107231412_b7-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"key20180107231412_b8-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b9-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"key20180107231412_b10-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J Immunol"},{"key":"key20180107231412_b11-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J Immunol"},{"key":"key20180107231412_b12-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4","article-title":"Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a \u2018fine-tuning cytokine\u2019 in inflammation processes","volume":"44","author":"Katz","year":"2001","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b13-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.2002.01782.x","article-title":"Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis","volume":"127","author":"Kehlen","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"key20180107231412_b14-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imlet.2004.01.014","article-title":"Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts","volume":"93","author":"Numasaki","year":"2004","journal-title":"Immunol Lett"},{"key":"key20180107231412_b15-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2004.11.012","article-title":"Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells","volume":"98","author":"Takahashi","year":"2005","journal-title":"Immunol Lett"},{"key":"key20180107231412_b16-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.10816","article-title":"Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy","volume":"48","author":"Miossec","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b17-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/ar1159","article-title":"Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes","volume":"6","author":"Granet","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"key20180107231412_b18-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T","article-title":"The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model","volume":"44","author":"Chabaud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b19-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.4049\/jimmunol.167.10.6015","article-title":"Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines","volume":"167","author":"Chabaud","year":"2001","journal-title":"J Immunol"},{"key":"key20180107231412_b20-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cyto.2004.03.002","article-title":"Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells","volume":"26","author":"Granet","year":"2004","journal-title":"Cytokine"},{"key":"key20180107231412_b21-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","article-title":"Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis","volume":"137","author":"Chevrel","year":"2003","journal-title":"J Neuroimmunol"},{"key":"key20180107231412_b22-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b23-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1006\/cyto.1997.0240","article-title":"Molecular characterization of the human interleukin (IL)-17 receptor","volume":"9","author":"Yao","year":"1997","journal-title":"Cytokine"},{"key":"key20180107231412_b24-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1272\/jnms.73.203","article-title":"Critical roles of capillary endothelial cells for alveolar remodeling in nonspecific and usual interstitial pneumonias","volume":"73","author":"Tachihara","year":"2006","journal-title":"J Nippon Med Sch"},{"key":"key20180107231412_b25-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/sj.onc.1203577","article-title":"Evi27 encodes a novel membrane protein with homology to the IL17 receptor","volume":"19","author":"Tian","year":"2000","journal-title":"Oncogene"},{"key":"key20180107231412_b26-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"19167","DOI":"10.1074\/jbc.M910228199","article-title":"A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity","volume":"275","author":"Shi","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107231412_b27-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1074\/jbc.M008289200","article-title":"IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107231412_b28-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4049\/jimmunol.180.1.655","article-title":"IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood","volume":"180","author":"Zrioual","year":"2008","journal-title":"J Immunol"},{"key":"key20180107231412_b29-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s000180300043","article-title":"The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells","volume":"60","author":"Miljkovic","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"key20180107231412_b30-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b31-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b32-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/CDLI.11.6.1075-1084.2004","article-title":"Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody","volume":"11","author":"Nardelli","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"key20180107231412_b33-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2249.1990.tb05353.x","article-title":"The effect of treatment with interferon-gamma on type II collagen-induced arthritis","volume":"81","author":"Nakajima","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"key20180107231412_b34-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1985.tb51182.x","article-title":"Type II collagen-induced arthritis","volume":"460","author":"Stuart","year":"1985","journal-title":"Ann NY Acad Sci"},{"key":"key20180107231412_b35-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J Immunol"},{"key":"key20180107231412_b36-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-8-17","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation","volume":"8","author":"Fan","year":"2011","journal-title":"Virol J"},{"key":"key20180107231412_b37-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"key20180107231412_b38-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1002\/art.37686","article-title":"Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency","volume":"64","author":"Bas","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20180107231412_b39-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-402-5_16","article-title":"Collagen antibody induced arthritis","volume":"136","author":"Nandakumar","year":"2007","journal-title":"Methods Mol Med"},{"key":"key20180107231412_b40-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol"},{"key":"key20180107231412_b41-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.4049\/jimmunol.170.9.4665","article-title":"Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways","volume":"170","author":"Miyamoto","year":"2003","journal-title":"J Immunol"},{"key":"key20180107231412_b42-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/jir.1996.16.611","article-title":"Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells","volume":"16","author":"Kennedy","year":"1996","journal-title":"J Interferon Cytokine Res"},{"key":"key20180107231412_b43-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/02713680902741696","article-title":"Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody","volume":"34","author":"Zhang","year":"2009","journal-title":"Curr Eye Res"},{"key":"key20180107231412_b44-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.intimp.2012.12.010","article-title":"Synergistic effects of interleukin-1beta and interleukin-17A antibodies on collagen-induced arthritis mouse model","volume":"15","author":"Zhang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"key20180107231412_b45-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.micinf.2009.04.003","article-title":"IL-17 and Th17 cells in human inflammatory diseases","volume":"11","author":"Miossec","year":"2009","journal-title":"Microbes Infect"},{"key":"key20180107231412_b46-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.autrev.2008.11.001","article-title":"Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes","volume":"8","author":"Bazzani","year":"2009","journal-title":"Autoimmun Rev"},{"key":"key20180107231412_b47-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3899\/jrheum.110421","article-title":"Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state","volume":"38","author":"Gandjbakhch","year":"2011","journal-title":"J Rheumatol"},{"key":"key20180107231412_b48-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/rheumatology\/kem257","article-title":"Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis","volume":"47","author":"Emery","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key20180107231412_b49-ijmm-33-03-0711","first-page":"1709","article-title":"Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy","volume":"35","author":"Hornung","year":"2008","journal-title":"J Rheumatol"},{"key":"key20180107231412_b50-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.4049\/jimmunol.1002016","article-title":"IL-17A and TNF-alpha exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro","volume":"186","author":"Liu","year":"2011","journal-title":"J Immunol"},{"key":"key20180107231412_b51-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"key20180107231412_b52-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0024-3205(97)00480-3","article-title":"Collagen-induced arthritis, an animal model of autoimmunity","volume":"61","author":"Myers","year":"1997","journal-title":"Life Sci"},{"key":"key20180107231412_b53-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.4049\/jimmunol.153.6.2758","article-title":"Collagen-induced arthritis and TCRs in SWR and B10. Q mice expressing an Ek alpha transgene","volume":"153","author":"Griffiths","year":"1994","journal-title":"J Immunol"},{"key":"key20180107231412_b54-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/clin.1994.1164","article-title":"Collagen-induced arthritis as a model of rheumatoid arthritis","volume":"73","author":"Durie","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"key20180107231412_b55-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.180.2.517","article-title":"Collagen-induced arthritis in T cell receptor V beta congenic B10","volume":"180","author":"Nabozny","year":"1994","journal-title":"Q mice J Exp Med"},{"key":"key20180107231412_b56-ijmm-33-03-0711","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2249.1994.tb06070.x","article-title":"CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice","volume":"97","author":"Kadowaki","year":"1994","journal-title":"Clin Exp Immunol"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2013.1611\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T09:12:36Z","timestamp":1688893956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2013.1611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,12,27]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.3892\/ijmm.2013.1611"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2013.1611","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,27]]}}}